Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. (Q53636339)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. |
scientific article |
Statements
Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. (English)
David C Christiani
Wei Zhou
Sarada Gurubhagavatula
Sohee Park
Donna S Neuberg
John C Wain
Thomas J Lynch
Li Su
1 August 2004
10
15
4939-4943